See more : MIC Electronics Limited (MIC.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Akili, Inc. (AKLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Akili, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Tulikivi Corporation (TULAV.HE) Income Statement Analysis – Financial Results
- Fayenceries de Sarreguemines, Digoin & Vitry-le-Francois Société Anonyme (FAYE.PA) Income Statement Analysis – Financial Results
- Aptech Limited (APTECHT.BO) Income Statement Analysis – Financial Results
- Gas Plus S.p.A. (GSP.MI) Income Statement Analysis – Financial Results
- Appliqate Inc. (APQT) Income Statement Analysis – Financial Results
Akili, Inc. (AKLI)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.akiliinteractive.com
About Akili, Inc.
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.68M | 323.00K | 538.00K | 3.94M | 19.99M |
| Cost of Revenue | 819.00K | 441.00K | 355.00K | 416.00K | 1.34M |
| Gross Profit | 859.00K | -118.00K | 183.00K | 3.52M | 18.64M |
| Gross Profit Ratio | 51.19% | -36.53% | 34.01% | 89.44% | 93.29% |
| Research & Development | 19.93M | 28.86M | 18.23M | 15.42M | 21.27M |
| General & Administrative | 38.84M | 53.84M | 29.78M | 13.54M | 18.88M |
| Selling & Marketing | 6.58M | 7.86M | 12.89M | 0.00 | 0.00 |
| SG&A | 45.42M | 61.70M | 42.67M | 13.54M | 18.88M |
| Other Expenses | 4.04M | 82.73M | 17.00K | 124.00K | 1.03M |
| Operating Expenses | 65.34M | 90.56M | 60.90M | 28.96M | 40.14M |
| Cost & Expenses | 66.16M | 91.00M | 61.26M | 29.38M | 41.48M |
| Interest Income | 0.00 | 1.48M | 8.32K | 333.00K | 157.00K |
| Interest Expense | 2.36M | 1.48M | 465.00K | 333.00K | 157.00K |
| Depreciation & Amortization | 302.00K | 308.00K | 296.00K | 424.00K | 1.29M |
| EBITDA | -60.14M | -88.89M | -60.44M | -25.01M | -20.21M |
| EBITDA Ratio | -3,584.21% | -28,073.37% | -11,231.04% | -634.98% | -101.14% |
| Operating Income | -64.49M | -90.68M | -60.72M | -25.44M | -21.50M |
| Operating Income Ratio | -3,842.97% | -28,073.37% | -11,286.06% | -645.75% | -107.57% |
| Total Other Income/Expenses | 5.05M | 82.73M | -629.00K | -209.00K | 877.00K |
| Income Before Tax | -59.49M | -7.95M | -61.35M | -25.65M | -20.62M |
| Income Before Tax Ratio | -3,545.47% | -2,459.75% | -11,402.97% | -651.05% | -103.18% |
| Income Tax Expense | 53.00K | 19.00K | 482.00K | 1.00K | 13.00K |
| Net Income | -59.49M | -7.96M | -61.83M | -25.65M | -20.63M |
| Net Income Ratio | -3,545.47% | -2,465.63% | -11,492.57% | -651.08% | -103.24% |
| EPS | -0.76 | -0.27 | -1.94 | -0.33 | -0.27 |
| EPS Diluted | -0.76 | -0.27 | -1.94 | -0.33 | -0.27 |
| Weighted Avg Shares Out | 78.20M | 29.88M | 31.89M | 77.86M | 77.86M |
| Weighted Avg Shares Out (Dil) | 78.20M | 29.88M | 31.89M | 77.86M | 77.86M |
Shareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair Price for its Public Shareholders
MILWAUKEE , May 29, 2024 /PRNewswire/ -- Ademi LLP is investigating Akili (Nasdaq: AKLI) for possible breaches of fiduciary duty and other violations of law in its transaction with Virtual Therapeutics. Click here to learn how to join the https://www.ademilaw.com/case/akili-inc or call Guri...
PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Akili Interactive and Virtual Therapeutics Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company.
Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company
KIRKLAND, Wash. & BOSTON--(BUSINESS WIRE)--Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, and Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced the signing of a definitive merger agreement to form...
Akili Reports First Quarter 2024 Financial Results and Provides Business Update
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter ended March 31, 2024 and provided an update on business progress. As announced in late April 2024, the Company's board of directors...
Why Is Akili (AKLI) Stock Up 68% Today?
Akili (NASDAQ: AKLI ) stock is rocketing higher on Tuesday after the digital medicine company provided investors with a positive corporate update. According to this update, Shionogi has canceled and forgiven $5 million in debt that Akili owed it.
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter and full year ended December 31, 2023, and provided an update on business progress. “We continue to see clear demand for our...
Should You Sell Your Penny Stocks? 3 Tips for When to Sell
Investing in penny stocks offers a unique opportunity for investors looking to expand their portfolios with potentially high-reward options. Recognized for their affordability, these stocks allow individuals to purchase shares in emerging companies without a significant financial outlay.
PureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in Japan
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that its Founded Entity Akili, Inc. (Nasdaq: AKLI) announced that its Japanese partner...
Why Is Akili (AKLI) Stock Up 110% Today?
A little known penny stock is turning heads on Wall Street today as it surges to impressive heights. Digital health company Akili Interactive Labs (NASDAQ: AKLI ) stock is soaring after reporting a positive trial update.
Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in Japan
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd has submitted Akili's digital therapeutic SDT-001 for marketing approval with the Ministry of Health, Labor, and Welfare. SDT-001 is the...
Source: https://incomestatements.info
Category: Stock Reports